Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.56 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.50 |
| ▸ | MGLL | Q99685 | 1/20 | 0.49 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.46 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL377011 | 0.84 | CES2 (0.62) | CES2SRD5A2LMNAHSD11B1MGLL | |
| SCHEMBL7418491 | 0.79 | HSD11B1 (0.56) | CES2SRD5A2LMNAHSD11B1MGLL | |
| Hydrochloric Acid SCHEMBL11517089 | 0.78 | HTR2C (0.56) | CES2SRD5A2LMNAHSD11B1MGLL | |
| SCHEMBL7456011 | 0.77 | CES2 (0.53) | CES2SRD5A2LMNAHSD11B1MGLL | |
| SCHEMBL1498423 | 0.75 | ELOVL6 (0.53) | CES2LMNANOTUMPOLBMEN1 | |
| SCHEMBL10476083 | 0.75 | ELOVL6 (0.53) | CES2LMNANOTUMPOLBMEN1 | |
| SCHEMBL1498422 | 0.75 | ELOVL6 (0.53) | CES2LMNANOTUMPOLBMEN1 | |
| SCHEMBL4848676 | 0.75 | CES2 (0.89) | CES2SRD5A2LMNAPOLBHPGD | |
| SCHEMBL29433907 | 0.75 | SRD5A2 (0.77) | CES2SRD5A2LMNAPOLBHPGD | |
| SCHEMBL40186 | 0.75 | SRD5A2 (0.77) | CES2SRD5A2LMNAPOLBHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011035159-A1 | ARYL SULPHONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | ZALICUS PHARMACEUTICALS LTD. (CA) | 2011-03-24 | — | — | WO | disclosed |